about
sameAs
Macrophage PPAR gamma Co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid.Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.Cyclooxygenase isoforms and atherosclerosis.Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cellsM1- and M2-Type Macrophage Responses Are Predictive of Adverse Outcomes in Human Atherosclerosis.Divergent effects of a CLA-enriched beef diet on metabolic health in ApoE-/- and ob/ob mice.Atheroprotective effects of conjugated linoleic acid.Milk-derived bioactive peptides and their health promoting effects: a potential role in atherosclerosis.NR4A Receptors Differentially Regulate NF-κB Signaling in Myeloid Cells.Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell.Profound resolution of early atherosclerosis with conjugated linoleic acid.Conjugated linoleic acid induces an atheroprotective macrophage MΦ2 phenotype and limits foam cell formation.Milk-derived bioactive peptides inhibit human endothelial-monocyte interactions via PPAR-γ dependent regulation of NF-κB.Induction of cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of alphavbeta3.Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse.Liraglutide dictates macrophage phenotype in apolipoprotein E null mice during early atherosclerosis.Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated Atherosclerosis.Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.Dysregulation of gene expression in human fetal endothelial cells from gestational diabetes in response to TGF-β1.Cyclooxygenase-2 inhibitors and atherosclerosisCyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosisConjugated linoleic acid targets β2 integrin expression to suppress monocyte adhesionLipoxins Protect Against Inflammation in Diabetes-Associated AtherosclerosisLiraglutide Attenuates Preestablished Atherosclerosis in Apolipoprotein E-Deficient Mice via Regulation of Immune Cell Phenotypes and Proinflammatory Mediators
P50
Q30551530-C1E3C03F-B562-4B9C-8221-B35C73F99302Q33195220-934EE9C0-9003-4EEE-B126-6842D939E52AQ35677194-66B6E288-E2E6-485F-8903-15BDB5E0AA5DQ36036258-49CAE1D8-00AF-4A8E-9730-5B80B1B9D914Q37104535-F9C83D62-227A-405E-850B-542FC4EC887FQ38325024-751CABB8-72F2-4359-BEB7-040E6F58D7FFQ38796198-20F53173-F6AC-4760-886A-8848BB4DDFCCQ38827062-3356B964-E14F-4788-94A0-65304C08C288Q38975224-A63F056B-83F3-44F5-825D-97731A3E010EQ39728848-0E4E9D0D-16E2-4579-ADBC-5BF1F0A82EDAQ40369355-B0D8387C-D9CB-4CD2-87D7-DAE64467B1F5Q41342312-B0A8AC47-8124-4CA9-8C0F-8571562C6FB2Q43121724-7757CCC2-73B8-4006-A16D-8B3A2048B21CQ44386872-3E4401D7-EA65-4BF0-9E80-BA6D817CC67FQ46207365-D4BFB3F2-3245-4F42-A9B1-19F12B14B12BQ46565724-F399057E-E912-4AB6-BE9E-16ED98AEC180Q47119800-4D55679C-342B-4C47-A1EF-762A1676CDB8Q48168452-6E5A757B-DEAD-44C6-9938-0994B85457AAQ51002334-7CE3AB2F-3560-420F-A42D-DF773495B000Q55062635-CEE2AC5A-EF53-4141-9175-015AC4D2CCC3Q73438403-6CA79957-DA69-41F5-B399-71EA17068CBDQ74206339-413447DF-C83D-43AA-94C4-CD5716C1D717Q85949127-E1AA8700-6A6E-4B1B-8EBF-FD0DEB5DEFFEQ91435385-8CCE1FC3-39E0-441A-8E6B-025D036C46CBQ91593036-83D7B3D0-3C70-4A8A-A9E5-C740D7DD5C4F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Orina Belton
@ast
Orina Belton
@en
Orina Belton
@nl
type
label
Orina Belton
@ast
Orina Belton
@en
Orina Belton
@nl
prefLabel
Orina Belton
@ast
Orina Belton
@en
Orina Belton
@nl
P106
P31
P496
0000-0002-7701-6540